Akihiro Pharmaceuticals Private Limited
About Akihiro Pharmaceuticals Private Limited
Data last updated:
Akihiro Pharmaceuticals Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 16 August 2024.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U21000KA2024PTC192116.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors including Girish Basavaraju and Thuraganur Mahadevu Manjunath.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bangalore, Karnataka.
Company details
Contact details
Akihiro Pharmaceuticals Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressNo 13 Shop No 1 50 Feet Road, 1st Cross Jnanakshi Layout Pattanagere, Bangalore, Karnataka, India – 560098
- IndustryPaper, Paper & Paper Products, Manufacturing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Akihiro Pharmaceuticals Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Akihiro Pharmaceuticals Private Limited, buy the company report.
Board of directors of Akihiro Pharmaceuticals Private Limited
Akihiro Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Girish Basavaraju Also directs: Nectamed Laboratories LLP, Rimo Pharmaceuticals Private Limited | Director | 16 Aug 2024 | 2 Years 2 Months | Current |
| Thuraganur Mahadevu Manjunath Also directs: Nectamed Laboratories LLP, Rimo Pharmaceuticals Private Limited | Director | 16 Aug 2024 | 2 Years 2 Months | Current |
| Amruthur Ranganatha Hemanth Kumar | Director | 23 Jul 2025 | 1 Years 3 Months | Current |
Legal cases
No court or tribunal cases involving Akihiro Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Akihiro Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Akihiro Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Akihiro Pharmaceuticals Private Limited has 5 board changes on record since 2024: 4 appointments and 1 cessation. The latest: Amruthur Ranganatha Hemanth Kumar was appointed as Director on 23 Jul 2025.
Frequently asked questions
Akihiro Pharmaceuticals is an active private limited company based in Bangalore, Karnataka, India. The company works in paper and paper products, within the paper industry. It was incorporated on 16 August 2024 (2+ years old) and is registered under CIN U21000KA2024PTC192116.
Akihiro Pharmaceuticals has 3 current directors:
- Girish Basavaraju - Director
- Thuraganur Mahadevu Manjunath - Director
- Amruthur Ranganatha Hemanth Kumar - Director
The latest financial statements of Akihiro Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Akihiro Pharmaceuticals is U21000KA2024PTC192116. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Akihiro Pharmaceuticals was incorporated on 16 August 2024, making it 2+ years old. It is registered with the Registrar of Companies, Bangalore.
Amruthur Ranganatha Hemanth Kumar was appointed as Director on 23 Jul 2025. Herur Narayana Swamy Kavya ceased to be Director on 23 Jul 2025. Girish Basavaraju was appointed as Director on 16 Aug 2024. Akihiro Pharmaceuticals has 5 board changes on record in total.
The registered office of Akihiro Pharmaceuticals is at No 13 Shop No 1 50 Feet Road, 1st Cross Jnanakshi Layout Pattanagere, Bangalore, Karnataka, India – 560098.
Akihiro Pharmaceuticals operates in the paper industry, in the paper and paper products segment.
Akihiro Pharmaceuticals can be reached at its registered office: No 13 Shop No 1 50 Feet Road, 1st Cross Jnanakshi Layout Pattanagere, Bangalore, Karnataka, India – 560098.
Akihiro Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Bangalore.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
